Endonovo Therapeutics, Inc.
ENDV· OTC
ENDVEndonovo Therapeutics, Inc.
Filed Nov 14, 2014 · 10-Q · 45 days after period end · 0001469709-14-000484
| Metric | Q3 2014 | Q3 2013 | Q3 2012 |
|---|---|---|---|
| Revenue | $20.64K | $0.00 | $7.16K |
| Net Income | $94.63K | -$452.40K | -$392.90K |
| EPS Diluted | $0.00 | -$0.01 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endonovo Therapeutics, Inc. · CIK 1528172 · Engraved from SEC EDGAR
ended Sep 30, 2014 · filed Nov 14, 2014 · 45 d after period end
